Drugs for Rheumatoid Arthritis: Global Markets to 2022

  • ID: 4480538
  • Report
  • Region: Global
  • 182 Pages
  • BCC Research
1 of 5
This Research Report Categorizes the Drugs for Rheumatoid Arthritis Market by Type

FEATURED COMPANIES

  • AbbVie Inc.
  • Amgen Inc.
  • Bristol-Myers Squibb
  • Hoffmann-La Roche
  • Johnson & Johnson
  • Pfizer
  • MORE

Report Scope:

This research report categorizes the drugs for rheumatoid arthritis market by type. Product type include disease modifying anti-rheumatic drugs, non-steroidal anti-inflammatory drugs and corticosteroids.

Report Includes:

  • 95 data tables
  • An overview of the global rheumatoid arthritis drugs market
  • Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Identification of segments with high growth potential and their future applications
  • Explanation of major drivers and regional dynamics of the market and current trends within the industry
  • Detailed profiles of major vendors in the market, including AbbVie Inc., Amgen Inc., Bristol-Myers Squibb, F. Hoffmann-La Roche AG and Pfizer Inc
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AbbVie Inc.
  • Amgen Inc.
  • Bristol-Myers Squibb
  • Hoffmann-La Roche
  • Johnson & Johnson
  • Pfizer
  • MORE

1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Currencies
  • Geographic Breakdown
  • Analyst's Credentials

2 Summary and Highlights

3 Drugs for Rheumatoid Arthritis Market Characteristics

4 Drugs for Rheumatoid Arthritis Market Size and Growth

  • Historic Market Growth
  • Drivers of the Market
  • Restraints on the Market
  • Forecast Market Growth
  • Drivers of the Market
  • Restraints on the Market

5 Drugs for Rheumatoid Arthritis Market Trends and Strategies

  • Increasing Use of Technology
  • 3D Printing Technologies
  • Combo and Mono Therapy
  • New Applications of NSAIDS

6 PESTLE Analysis

  • Political
  • Government Financial Support
  • Uncertain Political Policies
  • Economic
  • Wealth
  • Globalization
  • Emerging Markets
  • Social
  • Ageing Global Population
  • Sedentary Lifestyles
  • Health Consciousness and Awareness
  • Traditional Medicine Continues to Pose Threat to Market
  • Technological
  • 3D Printing Technologies
  • Internet Penetration and Mobile Applications
  • Legal
  • Stringent Regulations and Long Approval Procedures
  • Investment Regulations
  • Patent Issues
  • Government Intervention
  • Environmental

7 Drugs for Rheumatoid Arthritis Market Segmentation

  • Global Drugs for Rheumatoid Arthritis Market, By Segment
  • Global Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022
  • Disease Modifying Anti-Rheumatic Drugs (DMARDs)
  • Market Characteristics
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  • Market Characteristics
  • Corticosteroids
  • Market Characteristics

8 Drugs for Rheumatoid Arthritis Market Regional and Country Analysis

  • Global Drugs for Rheumatoid Arthritis Market, By Region
  • Global Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Region
  • Global Drugs for Rheumatoid Arthritis Market Segmentation, By Region, 2017
  • Global Drugs for Rheumatoid Arthritis Market, By Country
  • Global Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Country
  • Global Drugs for Rheumatoid Arthritis Market Segmentation, 2017, By Country

9 Global Drugs for Rheumatoid Arthritis Market Comparison with Macro Economic Factors

  • Global Per Capita Average Drugs for Rheumatoid Arthritis Market Expenditure
  • Per Capita Average Drugs for Rheumatoid Arthritis Market Expenditure, By Country

10 Asia-Pacific Drugs for Rheumatoid Arthritis Market

  • Asia-Pacific Drugs for Rheumatoid Arthritis Market Overview
  • Region Information
  • Background Information
  • End User Customer Information
  • Government Initiatives
  • Major Contracts/ Research and Development Projects
  • Regulatory Bodies
  • Regulations
  • Major Associations
  • Import and Export Duties
  • Taxes Levied
  • Corporate Tax Structure
  • Competitive Landscape
  • Asia-Pacific Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
  • Asia-Pacific Drugs for Rheumatoid Arthritis Market Forecast Market
  • Asia-Pacific Drugs for Rheumatoid Arthritis Market, By Segment
  • Asia-Pacific Drugs for Rheumatoid Arthritis Market, Historic and Forecast CAGR, By Segment

11 Asia-Pacific Drugs for Rheumatoid Arthritis Market: Country Analysis

  • China Drugs for Rheumatoid Arthritis Market Overview
  • Region Information
  • Background Information
  • End User Customer Information
  • Major Contracts/ Research and Development Projects
  • Regulatory Bodies
  • Regulations
  • Major Associations
  • Taxes Levied
  • Corporate Tax Structure
  • Competitive Landscape
  • China Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
  • China Drugs for Rheumatoid Arthritis Market Forecast Market, 2017-2022
  • China Market Size, By Segment
  • China Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment
  • India Drugs for Rheumatoid Arthritis Market Overview
  • Country Information
  • Background Information
  • End User Customer Information
  • Government Initiatives
  • Major Contracts/ Research and Development Projects
  • Regulatory Bodies
  • Regulations
  • Major Associations
  • Import and Export Duties
  • Taxes Levied
  • Corporate Tax Structure
  • Competitive Landscape
  • India Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
  • India Drugs for Rheumatoid Arthritis Market Forecast Market, 2017-2022
  • India Market Size, By Segment
  • India Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment
  • Japan Drugs for Rheumatoid Arthritis Market Overview
  • Region Information
  • Background Information
  • End User Customer Information
  • Major Contracts/ Research and Development Projects
  • Regulatory Bodies
  • Regulations
  • Taxes Levied
  • Corporate Tax Structure
  • Major Associations
  • Major Companies
  • Japan Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
  • Japan Drugs for Rheumatoid Arthritis Market Forecast Market, 2017-2022
  • Japan Market Size, By Segment
  • Japan Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment
  • Australia Drugs for Rheumatoid Arthritis Market
  • Australia Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
  • Australia Drugs for Rheumatoid Arthritis Market Forecast Market, 2017-2022
  • Australia Market Size, By Segment
  • Australia Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment

12 Western Europe Drugs for Rheumatoid Arthritis Market

  • Western European Drugs for Rheumatoid Arthritis Market Overview
  • Region Information
  • Background Information
  • End User Customer Information
  • Government Initiatives
  • Major Contracts/ Research and Development Projects
  • Regulatory Bodies
  • Regulations
  • Import and Export Duties
  • Taxes Levied
  • Corporate Tax Structure
  • Competitive Landscape
  • Western Europe Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
  • Western Europe Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
  • Western Europe Market Size, By Segment
  • Western Europe Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment

13 Western Europe Drugs for Rheumatoid Arthritis Market: Country Analysis

  • UK Drugs for Rheumatoid Arthritis Market Overview
  • Region Information
  • Background Information
  • End User Customer Information
  • Government Initiatives
  • Major Contracts/ Research and Development Projects
  • Regulatory Bodies
  • Regulations
  • Major Associations
  • Import and Export Duties
  • Taxes Levied
  • Corporate Tax Structure
  • Competitive Landscape
  • UK Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
  • UK Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
  • UK Market Size, By Segment
  • UK Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment
  • Germany Drugs for Rheumatoid Arthritis Market
  • Germany Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
  • Germany Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
  • Germany Market Size, By Segment
  • Germany Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment
  • France Drugs for Rheumatoid Arthritis Market
  • France Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
  • France Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
  • France Market Size, By Segment
  • France Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022
  • Italy Drugs for Rheumatoid Arthritis Market
  • Italy Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
  • Italy Drugs for Rheumatoid Arthritis Market Forecast Market, 2017-2022
  • Italy Market Size, By Segment
  • Italy Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022
  • Spain Drugs for Rheumatoid Arthritis Market
  • Spain Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
  • Spain Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
  • Spain Market Size, By Segment
  • Spain Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022

14 Eastern Europe Drugs for Rheumatoid Arthritis Market

  • Eastern European Drugs for Rheumatoid Arthritis Market Overview
  • Region Information
  • Background Information
  • End User Customer Information
  • Major Contracts/ Research and Development Projects
  • Regulatory Bodies
  • Regulations
  • Major Associations
  • Import and Export Duties
  • Taxes Levied
  • Corporate Tax Structure
  • Competitive Landscape
  • Eastern Europe Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
  • Eastern Europe Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
  • Eastern Europe Market Size, By Segment
  • Eastern Europe Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022

15 Eastern Europe Drugs for Rheumatoid Arthritis Market: Country Analysis

  • Russia Drugs for Rheumatoid Arthritis Market
  • Russia Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
  • Russia Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
  • Russia Market Size, By Segment
  • Russia Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022

16 North America Drugs for Rheumatoid Arthritis Market

  • North America Drugs for Rheumatoid Arthritis Market Overview
  • Region Information
  • Background Information
  • End User Customer Information
  • Government Initiatives
  • Major Contracts/ Research and Development Projects
  • Regulatory Bodies
  • Regulations
  • Major Associations
  • Taxes Levied
  • Corporate Tax Structure
  • Competitive Landscape
  • North America Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
  • North America Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
  • North America Market Size, By Segment
  • North America Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022

17 North America Drugs for Rheumatoid Arthritis Market: Country Analysis

  • USA Drugs for Rheumatoid Arthritis Market
  • USA Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
  • USA Drugs for Rheumatoid Arthritis Market Forecast Market, 2017-2022
  • USA Market Size, By Segment
  • USA Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment

18 South America Drugs for Rheumatoid Arthritis Market

  • South America Drugs for Rheumatoid Arthritis Market Overview
  • Region Information
  • Background Information
  • End User Customer Information
  • Government Initiatives
  • Major Contracts/ Research and Development Projects
  • Regulatory Bodies
  • Regulations
  • Major Associations
  • Import and Export Duties
  • Taxes Levied
  • Corporate Tax Structure
  • Competitive Landscape
  • South America Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
  • South America Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
  • South America Market Size, By Segment
  • South America Drugs for Rheumatoid Arthritis Historic and Forecast Market, By Segment, 2013-2022

19 South America Drugs for Rheumatoid Arthritis Market: Country Analysis

  • Brazil Drugs for Rheumatoid Arthritis M
  • Brazil Drugs for Rheumatoid Arthritis Historic Market, 2013-2016
  • Brazil Drugs for Rheumatoid Arthritis Market Forecast Market, 2017-2022
  • Brazil Market Size, By Segment
  • Brazil Drugs for Rheumatoid Arthritis Historic and Forecast Market, By Segment, 2013-2022

20 Middle East Drugs for Rheumatoid Arthritis Market

  • Middle Drugs for Rheumatoid Arthritis Market Overview
  • Region Information
  • Background Information
  • End User Customer Information
  • Government Initiatives
  • Major Contracts/ Research and Development Projects
  • Regulatory Bodies
  • Regulations
  • Major Associations
  • Import and Export Duties
  • Taxes Levied
  • Competitive Landscape
  • Middle East Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
  • Middle East Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
  • Middle East Market Size, By Segment
  • Middle East Drugs for Rheumatoid Arthritis Historic and Forecast Market, By Segment, 2013-2022

21 Africa Drugs for Rheumatoid Arthritis Market

  • Africa Drugs for Rheumatoid Arthritis Market Overview
  • Region Information
  • Background Information
  • End User Customer Information
  • Government Initiatives
  • Regulations
  • Regulatory Bodies
  • Major Associations
  • Competitive Landscape
  • Africa Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
  • Africa Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
  • Africa Market Size, By Segment
  • Africa Drugs for Rheumatoid Arthritis Historic and Forecast Market, By Segment, 2013-2022

22 Drugs for Rheumatoid Arthritis Market Customer Information

  • Frequency of Pain after Treatment
  • Different Symptoms Experienced by Patients
  • Impact of Rheumatoid Arthritis at Workplace
  • Importance of Patient’s Role in the Management of Rheumatoid Arthritis
  • Capacity of Affordable Treatment

23 Drugs for Rheumatoid Arthritis Market Competitive Landscape

  • Company Profiles
  • Abbvie Inc.
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche AG
  • Pfizer

24 Key Mergers and Acquisitions in the Drugs for Rheumatoid Arthritis Market

  • Pfizer Acquired Hospira
  • Concordia Healthcare Acquired Covis Pharma Commercial Assets
  • Bristol-Myers Squibb Acquired Padlock Therapeutics
  • Alvotech Acquired Baliopharm
  • Atnahs Acquired Pharmaceutical Assets of F. Hoffmann-La Roche

25 Appendix

  • Definitions of the Industry
  • Drugs for Rheumatoid Arthritis
  • Research Methodology

26 References

List of Tables
Summary Table : Global Drugs for Rheumatoid Arthritis Market, Through 2022
Table 1 : Global Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 2 : Global Drugs for Rheumatoid Arthritis Market, Through 2022
Table 3 : Global Drugs for Rheumatoid Arthritis Market, By Segment, 2017
Table 4 : Global Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, Through 2022
Table 5 : Global Drugs for Rheumatoid Arthritis Market, by Region, 2017
Table 6 : Global Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Region, Through 2022
Table 7 : Global Drugs for Rheumatoid Arthritis Market Segmentation, by Region, 2017
Table 8 : Global Drugs for Rheumatoid Arthritis Market, by Country, 2017
Table 9 : Global Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Country, 2013-2022
Table 10 : Global Drugs for Rheumatoid Arthritis Market Segmentation, by Country, 2017
Table 11 : Global Per Capita Average Drugs for Rheumatoid Arthritis Market Expenditure, 2013-2022
Table 12 : per Capita Average Drugs for Rheumatoid Arthritis Market Expenditure, by Country, 2017
Table 13 : Asia-Pacific-Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 14 : Asia-Pacific Drugs for Rheumatoid Arthritis Market, Through 2022
Table 15 : Asia-Pacific Drugs for Rheumatoid Arthritis Market, By Segment, 2017
Table 16 : Asia-Pacific Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Table 17 : China Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 18 : China Drugs for Rheumatoid Arthritis Market, Through 2022
Table 19 : China Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 20 : China Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 21 : India Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 22 : India Drugs for Rheumatoid Arthritis Market, Through 2022
Table 23 : India Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 24 : India Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 25 : Japan Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 26 : Japan Drugs for Rheumatoid Arthritis Market, Through 2022
Table 27 : Japan Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 28 : Japan Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 29 : Australia Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 30 : Australia Drugs for Rheumatoid Arthritis Market, Through 2022
Table 31 : Australia Drugs for Rheumatoid Arthritis Market, By Segment, 2017
Table 32 : Australia Drugs for Rheumatoid Arthritis Market Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 33 : Western Europe Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 34 : Western Europe Drugs for Rheumatoid Arthritis Market, Through 2022
Table 35 : Western Europe Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 36 : Western Europe Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 37 : UK Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 38 : UK Drugs for Rheumatoid Arthritis Market, Through 2022
Table 39 : UK Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 40 : UK Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 41 : Germany Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 42 : Germany Drugs for Rheumatoid Arthritis Market, Through 2022
Table 43 : Germany Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 44 : Germany Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 45 : France Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 46 : France Drugs for Rheumatoid Arthritis Market, Through 2022
Table 47 : France Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 48 : France Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 49 : Italy Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 50 : Italy Drugs for Rheumatoid Arthritis Market, Through 2022
Table 51 : Italy Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 52 : Italy Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 53 : Spain Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 54 : Spain Drugs for Rheumatoid Arthritis Market, 2017-2022
Table 55 : Spain Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 56 : Spain Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 57 : Eastern Europe Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 58 : Eastern Europe Drugs for Rheumatoid Arthritis Market, Through 2022
Table 59 : Eastern Europe Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 60 : Eastern Europe Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 61 : Russia Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 62 : Russia Drugs for Rheumatoid Arthritis Market, Through 2022
Table 63 : Russia Drugs for Rheumatoid Arthritis Market, By Segment, 2017
Table 64 : Russia Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 65 : North America Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 66 : North America Drugs for Rheumatoid Arthritis Market, Through 2022
Table 67 : North America Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 68 : North America Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 69 : USA Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 70 : USA Drugs for Rheumatoid Arthritis Market, Through 2022
Table 71 : USA Drugs for Rheumatoid Arthritis Market, By Segment, 2017
Table 72 : USA Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, Through 2022
Table 73 : South America Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 74 : South America Drugs for Rheumatoid Arthritis Market, Through 2022
Table 75 : South America Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 76 : South America Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, Through 2022
Table 77 : Brazil Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 78 : Brazil Drugs for Rheumatoid Arthritis Market, Through 2022
Table 79 : Brazil Drugs for Rheumatoid Arthritis Market, By Segment, 2017
Table 80 : Brazil Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 81 : Middle East Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 82 : Middle East Drugs for Rheumatoid Arthritis Market, Through 2022
Table 83 : Middle East Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 84 : Middle East Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 85 : Africa Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Table 86 : Africa Drugs for Rheumatoid Arthritis Market, Through 2022
Table 87 : Africa Drugs for Rheumatoid Arthritis Market, By Segment, 2017
Table 88 : Africa Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 89 : Global Market Shares for Key Competitors of Drugs for Rheumatoid Arthritis, 2017
Table 90 : AbbVie Inc. Financial Performance, 2013 - 2017
Table 91 : Amgen Inc. Financial Performance, 2013 - 2017
Table 92 : Bristol-Myers Squibb Financial Performance, 2013 - 2017
Table 93 : F. Hoffmann-La Roche Financial Performance, 2013 - 2017
Table 94 : Pfizer Inc. Financial Performance, 2013 - 2017
Table 95 : Market Data Sources

List of Figures
Summary Figure : Global Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 1 : Global Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 2 : Global Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 3 : PESTLE Analysis: Global drugs for rheumatoid arthritis market, 2017
Figure 4 : Global Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 5 : Global Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 6 : Global Drugs for Rheumatoid Arthritis Market Share, by Region, 2017
Figure 7 : Global Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Region, 2013-2022
Figure 8 : Global Drugs for Rheumatoid Arthritis Market Segmentation, by Region, 2017
Figure 9 : Global Drugs for Rheumatoid Arthritis Market Share, by Country, 2017
Figure 10 : Global Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Country, 2013-2022
Figure 11 : Global Drugs for Rheumatoid Arthritis Market Segmentation, by Country, 2017
Figure 12 : Global Per Capita Average Drugs for Rheumatoid Arthritis Market Expenditure, 2013-2022
Figure 13 : Asia-Pacific Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 14 : Asia-Pacific Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 15 : Asia-Pacific Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 16 : Asia-Pacific Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 17 : China Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 18 : China Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 19 : China Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 20 : China Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 21 : India Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 22 : India Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 23 : India Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 24 : India Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 25 : Japan Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 26 : Japan Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 27 : Japan Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 28 : Japan Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market by Segment, 2013-2022
Figure 29 : Australia Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 30 : Australia Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 31 : Australia Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 32 : Australia Drugs for Rheumatoid Arthritis Market Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 33 : Western Europe Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 34 : Western Europe Drugs for Rheumatoid Arthritis market, 2017-2022
Figure 35 : Western Europe Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 36 : Western Europe Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 37 : UK Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 38 : UK Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 39 : UK Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 40 : UK Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 41 : Germany Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 42 : Germany Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 43 : Germany Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 44 : Germany Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 45 : France Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 46 : France Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 47 : France Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 48 : France Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 49 : Italy Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 50 : Italy Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 51 : Italy Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 52 : Italy Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 53 : Spain Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 54 : Spain Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 55 : Spain Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 56 : Spain Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 57 : Eastern Europe Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 58 : Eastern Europe Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 59 : Eastern Europe Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 60 : Eastern Europe Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Figure 61 : Russia Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 62 : Russia Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 63 : Russia Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 64 : Russia Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 65 : North America Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 66 : North America Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 67 : North America Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 68 : North America Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 69 : USA Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 70 : USA Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 71 : USA Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 72 : USA Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 73 : South America Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 74 : South America Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 75 : South America Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 76 : South America Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 77 : Brazil Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 78 : Brazil Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 79 : Brazil Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 80 : Brazil Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Figure 81 : Middle East Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 82 : Middle East Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 83 : Middle East Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 84 : Middle East Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Figure 85 : Africa Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 86 : Africa Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 87 : Africa Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 88 : Africa Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Figure 89 : Global Market Shares for Key Competitors of Drugs for Rheumatoid Arthritis, 2017
Figure 90 : AbbVie Inc. Financial Performance, 2013-2017
Figure 91 : Amgen Inc. Financial Performance, 2013-2017
Figure 92 : Bristol-Myers Squibb Financial Performance, 2013-2017
Figure 93 : F. Hoffmann-La Roche Financial Performance, 2013-2017
Figure 94 : Pfizer Inc. Financial Performance, 2013-2017

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • AbbVie Inc.
  • Amgen Inc.
  • Biogen 0.6 10.8 Merck & Co.
  • Bristol-Myers Squibb
  • Hoffmann-La Roche
  • Johnson & Johnson
  • Mitsubishi Tanabe Pharma Corporation
  • Pfizer
  • UCB S.A.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll